UBS Maintains Neutral on Docusign, Lowers Price Target to $54

Benzinga Newsdesk www.benzinga.com Negative 80.3%

Neg 80.3% Neu 0% Pos 0%

UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and lowers the price target from $75 to $54.

Comments

No comments yet. Be the first!